These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33924410)

  • 1. Editorial for Special Issue "Bioactive Oxadiazoles".
    Palumbo Piccionello A
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioactive Oxadiazoles 2.0.
    Palumbo Piccionello A
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,2,4-Oxadiazole as a Privileged Scaffold for Anti-inflammatory and Analgesic Activities: A Review.
    Chawla G
    Mini Rev Med Chem; 2018; 18(18):1536-1547. PubMed ID: 29792145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [1, 2, 4]-oxadiazoles: synthesis and biological applications.
    Bora RO; Dar B; Pradhan V; Farooqui M
    Mini Rev Med Chem; 2014 Apr; 14(4):355-69. PubMed ID: 24678879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel 1,2,4-oxadiazoles and 1,2,4-thiadiazoles as dual 5-lipoxygenase and cyclooxygenase inhibitors.
    Unangst PC; Shrum GP; Connor DT; Dyer RD; Schrier DJ
    J Med Chem; 1992 Oct; 35(20):3691-8. PubMed ID: 1433181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of 5-(3,5-di-tert-butyl-4-hydroxyphenyl)-1,3,4-thiadiazoles, -1,3,4-oxadiazoles, and -1,2,4-triazoles as orally-active, nonulcerogenic antiinflammatory agents.
    Mullican MD; Wilson MW; Connor DT; Kostlan CR; Schrier DJ; Dyer RD
    J Med Chem; 1993 Apr; 36(8):1090-9. PubMed ID: 8478906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxadiazoles in medicinal chemistry.
    Boström J; Hogner A; Llinàs A; Wellner E; Plowright AT
    J Med Chem; 2012 Mar; 55(5):1817-30. PubMed ID: 22185670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Furazans in Medicinal Chemistry.
    Mancini RS; Barden CJ; Weaver DF; Reed MA
    J Med Chem; 2021 Feb; 64(4):1786-1815. PubMed ID: 33569941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxadiazole scaffolds in anti-tuberculosis drug discovery.
    De SS; Khambete MP; Degani MS
    Bioorg Med Chem Lett; 2019 Aug; 29(16):1999-2007. PubMed ID: 31296357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of 3,5-disubstituted-1,2,4-oxadiazoles as potent inhibitors of phosphodiesterase4b2.
    Kumar D; Patel G; Vijayakrishnan L; Dastidar SG; Ray A
    Chem Biol Drug Des; 2012 May; 79(5):810-8. PubMed ID: 22176507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and Biological Activities of Oxadiazole Derivatives: A Review.
    Vaidya A; Jain S; Jain P; Jain P; Tiwari N; Jain R; Jain R; Jain AK; Agrawal RK
    Mini Rev Med Chem; 2016; 16(10):825-45. PubMed ID: 26864552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fenbufen based 3-[5-(substituted aryl)-1,3,4-oxadiazol-2-yl]-1-(biphenyl-4-yl)propan-1-ones as safer antiinflammatory and analgesic agents.
    Husain A; Ahmad A; Alam MM; Ajmal M; Ahuja P
    Eur J Med Chem; 2009 Sep; 44(9):3798-804. PubMed ID: 19457595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, characterization, evaluation and molecular dynamics studies of 5, 6-diphenyl-1,2,4-triazin-3(2H)-one derivatives bearing 5-substituted 1,3,4-oxadiazole as potential anti-inflammatory and analgesic agents.
    Banerjee AG; Das N; Shengule SA; Srivastava RS; Shrivastava SK
    Eur J Med Chem; 2015 Aug; 101():81-95. PubMed ID: 26117820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New 1,3,4-oxadiazole/oxime hybrids: Design, synthesis, anti-inflammatory, COX inhibitory activities and ulcerogenic liability.
    Abd-Ellah HS; Abdel-Aziz M; Shoman ME; Beshr EAM; Kaoud T; Ahmed AFF
    Bioorg Chem; 2017 Oct; 74():15-29. PubMed ID: 28738249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of novel HDAC8 inhibitory 2,5-disubstituted-1,3,4-oxadiazoles containing glycine and alanine hybrids with anti cancer activity.
    Pidugu VR; Yarla NS; Pedada SR; Kalle AM; Satya AK
    Bioorg Med Chem; 2016 Nov; 24(21):5611-5617. PubMed ID: 27665180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and anti-tumor activity of glycosyl oxadiazoles derivatives.
    Du K; Cao X; Zhang P; Zheng H
    Bioorg Med Chem Lett; 2014 Nov; 24(22):5318-20. PubMed ID: 25278236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monofunctional platinum complexes containing a 4-nitrobenzo-2-oxa-1,3-diazole fluorophore: distribution in tumour cells.
    Wu S; Wang X; Zhu C; Song Y; Wang J; Li Y; Guo Z
    Dalton Trans; 2011 Oct; 40(40):10376-82. PubMed ID: 21681330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Review Exploring Therapeutic Worth of 1,3,4-Oxadiazole Tailored Compounds.
    Verma G; Khan MF; Akhtar W; Alam MM; Akhter M; Shaquiquzzaman M
    Mini Rev Med Chem; 2019; 19(6):477-509. PubMed ID: 30324877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of new orally effective analgesic and anti-inflammatory hybrid furoxanyl N-acylhydrazone derivatives.
    Hernández P; Cabrera M; Lavaggi ML; Celano L; Tiscornia I; Rodrigues da Costa T; Thomson L; Bollati-Fogolín M; Miranda AL; Lima LM; Barreiro EJ; González M; Cerecetto H
    Bioorg Med Chem; 2012 Mar; 20(6):2158-71. PubMed ID: 22356737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antioxidant activity of styrylsulfonylmethyl 1,3,4-oxadiazoles, pyrazolyl/isoxazolyl-1,3,4-oxadiazoles.
    Mallikarjuna Reddy G; Muralikrishna A; Padmavathi V; Padmaja A; Krishna Tilak T; Appa Rao C
    Chem Pharm Bull (Tokyo); 2013; 61(12):1291-7. PubMed ID: 24292790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.